The Biden administration released a new five-year plan for the global response on World AIDS Day, reaffirming its commitment to ending the HIV/AIDS epidemic by 2030.
The US Centers for Disease Control and Prevention estimate that at the end of 2019, more than 1.1 million Americans have HIV.
The administration announced on Thursday that it is speeding up its response to HIV/AIDS with new global goals, including achieving key treatment targets across age, gender, and population groups; supporting UNAIDS targets to reduce new HIV infections; and bridging equity gaps for specific groups, including young girls, children, and adolescents.
As of September 30, the US President’s Emergency Plan for AIDS Relief, or PEPFAR, said it has funded antiretroviral therapy for more than 20 million men, women, and children.
On World AIDS Day in 2021, President Joe Biden unveiled a new national HIV/AIDS strategy, saying “We are within striking distance of eliminating HIV transmission.” The US strategy goals include preventing new HIV infections, improving health outcomes for people with HIV, reducing health inequity and establishing a more coordinated effort to address the epidemic.
From 18.96 million in the fiscal year 2021, that is an increase.
According to PEPFAR’s most recent findings, 64.7 million people received HIV testing services financed by the programme, and 5.5 million newborns were spared HIV infection during birth.
In his budget proposal for 2023, President Joe Biden sought $850 million for HIV prevention and treatment initiatives. He also suggested the establishment of a roughly $10 billion nationwide PrEP programme to ensure pre-exposure prophylaxis and services for those without insurance or inadequate coverage.
Globally, the fight against HIV and AIDS has made mixed progress. Although advances have made the diagnosis more tolerable and even helped prevent infection, there is currently no vaccine or cure for HIV despite ambitious aspirations to end the disease. Black and Hispanic Americans are disproportionately affected by HIV in the United States due to vast discrepancies in access to treatment.
Parvathy Sukumaran 
